umeclidinium (Incruse Ellipta)

From Aaushi
Jump to navigation Jump to search

Introduction

FDA-approval recommended for combination with vilanterol

Indications

Dosage

Adverse effects

More general terms

Component of

References

  1. Physician's First Watch, September 12, 2013 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
  2. Medscape. April 30, 2014 FDA OKs Umeclidinium (Incruse Ellipta) for COPD. http://www.medscape.com/viewarticle/824419

Database